Ireland
--:--IST
Latest
Clinical Trials in France / NCT07797439
Starting soon Not applicable

Neuromotor Task Training in Autistic Children With Motor Difficulties

NCT07797439 · tracked via the Priya Life Science France tracker
Sponsor
Groupe Hospitalier Nord-Essonne
Phase
Not applicable
Started
2026-10
Last updated
2026-09-25

Condition(s) studied

Autism Spectrum Disorder (ASD)

Investigational drug(s) / intervention(s)

Neuromotor Task Training

Neuromotor Task Training: Neuromotor Task Training is a task-oriented rehabilitation approach focused on the practice of meaningful functional motor skills. The therapist analyzes the selected task and adapts task constraints, environmental conditions, practice organization, and feedback to support motor learning. In this study, each participant will receive Neuromotor Task Training sessions targeting an individualized motor skill selected before the intervention phase.

Study summary

The goal of this clinical study is to learn whether Neuromotor Task Training (NTT) may help improve functional motor skills in autistic children who have motor difficulties.

The main question it aims to answer is:

Does Neuromotor Task Training help autistic children improve a motor skill that is difficult for them in daily life?

This study will include autistic children with motor difficulties. Each child will work on one functional motor skill chosen according to their needs and daily-life goals. Examples may include skills such as catching a ball, jumping rope, putting on a coat, or another meaningful motor task.

Participants will take part in an initial assessment of their motor abilities. They will then choose, with their family and the researcher, a functional motor skill to work on. The selected skill will be assessed repeatedly before, during, and after the training period. Participants will receive Neuromotor Task Training sessions focused on this skill. They will also be followed after the training period to see whether the motor skill is maintained.

Neuromotor Task Training is a task-oriented rehabilitation approach. It focuses on practicing meaningful motor skills in conditions that are progressively adapted to the child. The task, the environment, and the feedback provided by the therapist may be adjusted during the sessions to support motor learning.

This study uses a single-case experimental design. This means that each participant's progress is measured repeatedly over time. The researchers will examine whether motor performance changes after the start of the training and whether these changes are maintained after the training period.

Eligibility

Sex
ALL
Min age
6 Years
Max age
10 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged 6 to 10 years. * Diagnosis of autism spectrum disorder. * Presence of motor difficulties documented by clinical assessment and/or standardized motor assessment. * Ability to understand and participate in the proposed motor training sessions. * Written informed consent from the child's legal representative(s). * Child assent whenever possible, according to age and level of understanding. * Participation in the usual care pathway at the investigating center. Exclusion Criteria: * Intelligence quotient below 70, when documented, or severe cognitive impairment preventing understanding of the tasks or participation in the training sessions. * Medical, neurological, orthopedic, or sensory condition that would contraindicate participation in motor training. * Uncontrolled epilepsy or any unstable medical condition that could interfere with participation. * Severe behavioral difficulties making repeated assessment or motor training impossible. * Ongoing participation in another interventional study that could interfere with the outcomes of this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Groupe Hospitalier Nord-Essonne Bures-sur-Yvette Essone

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07797439 on ClinicalTrials.gov ↗ ← All trials in France